01:26 PM EDT, 09/19/2025 (MT Newswires) -- Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index easing 0.1% and the Health Care Select Sector SPDR Fund (XLV) adding 0.1%.

The iShares Biotechnology ETF (IBB) was shedding 0.4%.

In corporate news, Amgen's ( AMGN ) Uplizna has received a positive opinion from the European Medicines Agency's human medicines committee recommending its approval for adults with active immunoglobulin G4-related disease, a rare autoimmune disorder with no authorized treatments in the EU. Amgen ( AMGN ) shares rose 3%.